VOGLISUG-TRIO 0.3 Tablets
MRP: 2,645
Packaging: 10X10
Pack Type: tablet
Composition:
Gliclazide 80mg + Metformin Hcl. 500mg + Voglibose 0.3mg
Indication:
Gliclazide 80mg + Metformin Hcl. 500mg + Voglibose 0.3mg
Description:
Gliclazide 80mg + Metformin HCl 500mg + Voglibose 0.3mg is a triple combination oral antidiabetic medication used in the management of type 2 diabetes mellitus. It targets multiple pathways to provide effective glycemic control:
Gliclazide, a sulfonylurea, increases insulin secretion from pancreatic β-cells.
Metformin, a biguanide, decreases hepatic glucose production and enhances peripheral insulin sensitivity.
Voglibose, an alpha-glucosidase inhibitor, delays carbohydrate absorption in the intestine to control postprandial blood sugar spikes.
This triple-action formulation is recommended for patients with inadequate blood glucose control using monotherapy or dual therapy. It is especially effective in managing both fasting and postprandial blood glucose levels.
Tags:
- Comprehensive control over fasting and postprandial glucose levels
- Triple action addresses insulin secretion, insulin resistance, and glucose absorption
- Improves glycemic control in patients with poor response to single or dual therapy
- Reduces risk of diabetes complications
- Convenient fixed-dose formulation improves compliance
Usage Information
Dosage
Typical Adult Dose: One tablet (Gliclazide 80mg + Metformin 500mg + Voglibose 0.3mg) taken with meals, usually twice daily. Note: Dose must be individualized based on blood sugar response and patient tolerance. Always follow the doctor’s instructions.
Side Effects
Common side effects: Hypoglycemia (especially if meals are skipped) Nausea, diarrhea, flatulence Abdominal bloating or discomfort Metallic taste in mouth Rare but serious side effects: Lactic acidosis (from Metformin) Liver dysfunction Skin reactions (rash, itching)
Contraindications
Type 1 diabetes Diabetic ketoacidosis Severe kidney or liver impairment History of lactic acidosis Gastrointestinal disorders (inflammatory bowel disease, intestinal obstruction) Hypersensitivity to any of the active ingredients
Availability
Gliclazide Metformin Voglibose tablets Triple combination diabetes medicine Type 2 diabetes triple therapy Gliclazide 80mg Metformin 500mg Voglibose 0.3mg Diabetes tablets for sugar control Oral antidiabetic combination therapy Blood sugar control medicine Postprandial blood sugar tablets